{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:52:54Z","timestamp":1790045574236,"version":"4.0.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/13\/2\/2019-NCD-III"],"award-info":[{"award-number":["5\/13\/2\/2019-NCD-III"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mazumdar Shaw Medical Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-026-01373-5","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T15:14:08Z","timestamp":1777907648000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Transcriptomic landscape of oral potentially malignant disorders: a meta-analysis approach"],"prefix":"10.1007","volume":"39","author":[{"given":"Vaishnav","family":"Vasudevan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gangotri","family":"Siddappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reba Elsa","family":"Sam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. K.","family":"Madhumathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anela","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumsum P.","family":"Sunny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidya","family":"Bhushan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh","family":"Dokhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Birur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moni A.","family":"Kuriakose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0785-0054","authenticated-orcid":false,"given":"Amritha","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"key":"1373_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2019.104550","volume":"102","author":"S Warnakulasuriya","year":"2020","unstructured":"Warnakulasuriya S. Oral potentially malignant disorders: a comprehensive review on clinical aspects and management. Oral Oncol. 2020;102:104550.","journal-title":"Oral Oncol"},{"key":"1373_CR2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/hed.26006","volume":"42","author":"O Iocca","year":"2020","unstructured":"Iocca O, Sollecito TP, Alawi F, et al. Potentially malignant disorders of the oral cavity and oral dysplasia: a systematic review and meta-analysis of malignant transformation rate by subtype. Head Neck. 2020;42:539\u201355.","journal-title":"Head Neck"},{"key":"1373_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/jop.13090","volume":"50","author":"HP Sathasivam","year":"2021","unstructured":"Sathasivam HP, Casement J, Bates T, et al. Gene expression changes associated with malignant transformation of oral potentially malignant disorders. J Oral Pathol Med. 2021;50:60\u20137.","journal-title":"J Oral Pathol Med"},{"key":"1373_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12030577","author":"J Zdrojewski","year":"2024","unstructured":"Zdrojewski J, Nowak M, Nijakowski K, et al. Potential immunohistochemical biomarkers for grading oral dysplasia: a literature review. Biomedicines. 2024. https:\/\/doi.org\/10.3390\/biomedicines12030577.","journal-title":"Biomedicines"},{"key":"1373_CR5","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1158\/1940-6207.CAPR-12-0173","volume":"5","author":"L Zhang","year":"2012","unstructured":"Zhang L, Poh CF, Williams M, et al. Loss of heterozygosity (LOH) profiles\u2013validated risk predictors for progression to oral cancer. Cancer Prev Res (Phila). 2012;5:1081\u20139.","journal-title":"Cancer Prev Res (Phila)"},{"key":"1373_CR6","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1158\/1940-6207.CAPR-09-0163","volume":"3","author":"M Taoudi Benchekroun","year":"2010","unstructured":"Taoudi Benchekroun M, Saintigny P, Thomas SM, et al. Epidermal growth factor receptor expression and gene copy number in the risk of oral cancer. Cancer Prev Res (Phila). 2010;3:800\u20139.","journal-title":"Cancer Prev Res (Phila)"},{"key":"1373_CR7","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s00262-011-1154-8","volume":"61","author":"AM De Costa","year":"2012","unstructured":"De Costa AM, Schuyler CA, Walker DD, Young MR. Characterization of the evolution of immune phenotype during the development and progression of squamous cell carcinoma of the head and neck. Cancer Immunol Immunother. 2012;61:927\u201339.","journal-title":"Cancer Immunol Immunother"},{"key":"1373_CR8","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1038\/sj.bjc.6600282","volume":"86","author":"G Gannot","year":"2002","unstructured":"Gannot G, Gannot I, Vered H, Buchner A, Keisari Y. Increase in immune cell infiltration with progression of oral epithelium from hyperkeratosis to dysplasia and carcinoma. Br J Cancer. 2002;86:1444\u20138.","journal-title":"Br J Cancer"},{"key":"1373_CR9","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1496880","volume":"7","author":"JP Foy","year":"2018","unstructured":"Foy JP, Bertolus C, Ortiz-Cuaran S, et al. Immunological and classical subtypes of oral premalignant lesions. Oncoimmunology. 2018;7:e1496880.","journal-title":"Oncoimmunology"},{"key":"1373_CR10","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1388484","volume":"7","author":"Y Chen","year":"2018","unstructured":"Chen Y, Li Q, Li X, et al. Blockade of PD-1 effectively inhibits in vivo malignant transformation of oral mucosa. Oncoimmunology. 2018;7:e1388484.","journal-title":"Oncoimmunology"},{"key":"1373_CR11","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1158\/1940-6207.CAPR-17-0108","volume":"10","author":"J Wang","year":"2017","unstructured":"Wang J, Xie T, Wang B, et al. PD-1 blockade prevents the development and progression of carcinogen-induced oral premalignant lesions. Cancer Prev Res (Phila). 2017;10:684\u201393.","journal-title":"Cancer Prev Res (Phila)"},{"key":"1373_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-02191-0","volume":"18","author":"M Weber","year":"2020","unstructured":"Weber M, Wehrhan F, Baran C, et al. Malignant transformation of oral leukoplakia is associated with macrophage polarization. J Transl Med. 2020;18:11.","journal-title":"J Transl Med"},{"key":"1373_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23168940","author":"S Deng","year":"2022","unstructured":"Deng S, Wang S, Shi X, Zhou H. Microenvironment in oral potentially malignant disorders: multi-dimensional characteristics and mechanisms of carcinogenesis. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23168940.","journal-title":"Int J Mol Sci"},{"key":"1373_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13153696","author":"L Lorini","year":"2021","unstructured":"Lorini L, Bescos Atin C, Thavaraj S, et al. Overview of oral potentially malignant disorders: from risk factors to specific therapies. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13153696.","journal-title":"Cancers (Basel)"},{"key":"1373_CR15","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.3892\/mmr.2016.5005","volume":"13","author":"K Yan","year":"2016","unstructured":"Yan K, Gao LN, Cui YL, Zhang Y, Zhou X. The cyclic AMP signaling pathway: exploring targets for successful drug discovery (Review). Mol Med Rep. 2016;13:3715\u201323.","journal-title":"Mol Med Rep"},{"key":"1373_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10081840","author":"S Surendran","year":"2022","unstructured":"Surendran S, Aboelkheir U, Tu AA, et al. T-cell infiltration and immune checkpoint expression increase in oral cavity premalignant and malignant disorders. Biomedicines. 2022. https:\/\/doi.org\/10.3390\/biomedicines10081840.","journal-title":"Biomedicines"},{"key":"1373_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13019-024-02625-x","volume":"19","author":"HZ Zheng","year":"2024","unstructured":"Zheng HZ, Miao X, Chang J, et al. Smoking behavior associated upregulation of SERPINB12 promotes proliferation and metastasis via activating WNT signaling in NSCLC. J Cardiothorac Surg. 2024;19:141.","journal-title":"J Cardiothorac Surg"},{"key":"1373_CR18","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3233\/CBM-203105","volume":"31","author":"Y Kang","year":"2021","unstructured":"Kang Y, Chen J, Li X, et al. Salivary KLK5 and uPA are potential biomarkers for malignant transformation of OLK and OLP. Cancer Biomark. 2021;31:317\u201328.","journal-title":"Cancer Biomark"},{"key":"1373_CR19","first-page":"197","volume":"24","author":"JR Pettus","year":"2009","unstructured":"Pettus JR, Johnson JJ, Shi Z, et al. Multiple kallikrein (KLK 5, 7, 8, and 10) expression in squamous cell carcinoma of the oral cavity. Histol Histopathol. 2009;24:197\u2013207.","journal-title":"Histol Histopathol"},{"key":"1373_CR20","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.clinbiochem.2011.04.006","volume":"44","author":"W Guo","year":"2011","unstructured":"Guo W, Dong Z, Guo Y, Chen Z, Kuang G, Yang Z. Aberrant methylation of the CpG island of HLTF gene in gastric cardia adenocarcinoma and dysplasia. Clin Biochem. 2011;44:784\u20138.","journal-title":"Clin Biochem"},{"key":"1373_CR21","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1016\/j.oooo.2024.04.018","volume":"138","author":"M Huang","year":"2024","unstructured":"Huang M, Sakhdari A, Aiman A, Guidos C, Magalhaes M. Characterizing oral dysplasia immune microenvironment (DIME) using imaging mass cytometry. Oral Surg Oral Med Oral Pathol Oral Radiol. 2024;138:e33\u20134.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"1373_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.954567","volume":"13","author":"CP Gan","year":"2022","unstructured":"Gan CP, Lee BKB, Lau SH, et al. Transcriptional analysis highlights three distinct immune profiles of high-risk oral epithelial dysplasia. Front Immunol. 2022;13:954567.","journal-title":"Front Immunol"},{"key":"1373_CR23","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.trsl.2013.06.008","volume":"162","author":"W Chen","year":"2013","unstructured":"Chen W, Harbeck MC, Zhang W, Jacobson JR. MicroRNA regulation of integrins. Transl Res. 2013;162:133\u201343.","journal-title":"Transl Res"},{"key":"1373_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/gpbjnl\/qzae035","author":"C Zou","year":"2024","unstructured":"Zou C, Zhu J, Xiong J, et al. Comprehensive characterization of the integrin family across 32 cancer types. Genomics Proteomics Bioinformatics. 2024. https:\/\/doi.org\/10.1093\/gpbjnl\/qzae035.","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"1373_CR25","doi-asserted-by":"publisher","first-page":"33494","DOI":"10.1074\/jbc.C113.497446","volume":"288","author":"LM Uotila","year":"2013","unstructured":"Uotila LM, Aatonen M, Gahmberg CG. Integrin CD11c\/CD18 alpha-chain phosphorylation is functionally important. J Biol Chem. 2013;288:33494\u20139.","journal-title":"J Biol Chem"},{"key":"1373_CR26","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41556-018-0223-z","volume":"21","author":"P Moreno-Layseca","year":"2019","unstructured":"Moreno-Layseca P, Icha J, Hamidi H, Ivaska J. Integrin trafficking in cells and tissues. Nat Cell Biol. 2019;21:122\u201332.","journal-title":"Nat Cell Biol"},{"key":"1373_CR27","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12964-025-02216-w","volume":"23","author":"M Tian","year":"2025","unstructured":"Tian M, Li X, Yu L, et al. Glycosylation as an intricate post-translational modification process takes part in glycoproteins related immunity. Cell Commun Signal. 2025;23:214.","journal-title":"Cell Commun Signal"},{"key":"1373_CR28","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/jop.13440","volume":"52","author":"JY Guan","year":"2023","unstructured":"Guan JY, Luo YH, Lin YY, et al. Malignant transformation rate of oral leukoplakia in the past 20 years: a systematic review and meta-analysis. J Oral Pathol Med. 2023;52:691\u2013700.","journal-title":"J Oral Pathol Med"},{"key":"1373_CR29","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.157285","author":"CY Hsieh","year":"2022","unstructured":"Hsieh CY, Lin CC, Huang YW, et al. Macrophage secretory IL-1beta promotes docetaxel resistance in head and neck squamous carcinoma via SOD2\/CAT-ICAM1 signaling. JCI Insight. 2022. https:\/\/doi.org\/10.1172\/jci.insight.157285.","journal-title":"JCI Insight"},{"key":"1373_CR30","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.2147\/CMAR.S237443","volume":"12","author":"S Chen","year":"2020","unstructured":"Chen S, Pan S, Wu H, et al. ICAM1 regulates the development of gastric cancer and may be a potential biomarker for the early diagnosis and prognosis of gastric cancer. Cancer Manag Res. 2020;12:1523\u201334.","journal-title":"Cancer Manag Res"},{"key":"1373_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2025.102428","volume":"58","author":"Y Ding","year":"2025","unstructured":"Ding Y, Shan Y, Gu J, Yi J, Sun Z. IL1RA inhibits the progression of oral squamous cell carcinoma by mediating type \u2160 interferon response. Transl Oncol. 2025;58:102428.","journal-title":"Transl Oncol"},{"key":"1373_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17081279","author":"G Xie","year":"2025","unstructured":"Xie G, Yang C, Pang X, Wu TC, Gu X. Cancer cell-intrinsic type I interferon signaling promotes antitumor immunity in head and neck squamous cell carcinoma. Cancers (Basel). 2025. https:\/\/doi.org\/10.3390\/cancers17081279.","journal-title":"Cancers (Basel)"},{"key":"1373_CR33","doi-asserted-by":"publisher","first-page":"4707","DOI":"10.1158\/0008-5472.CAN-04-4173","volume":"65","author":"JG Jiang","year":"2005","unstructured":"Jiang JG, Chen CL, Card JW, et al. Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors. Cancer Res. 2005;65:4707\u201315.","journal-title":"Cancer Res"},{"key":"1373_CR34","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1182\/blood-2004-12-4664","volume":"106","author":"GG Wang","year":"2005","unstructured":"Wang GG, Pasillas MP, Kamps MP. Meis1 programs transcription of FLT3 and cancer stem cell character, using a mechanism that requires interaction with Pbx and a novel function of the Meis1 C-terminus. Blood. 2005;106:254\u201364.","journal-title":"Blood"},{"key":"1373_CR35","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1186\/s13058-014-0465-z","volume":"16","author":"X Li","year":"2014","unstructured":"Li X, Liang W, Liu J, et al. Transducin (beta)-like 1 X-linked receptor 1 promotes proliferation and tumorigenicity in human breast cancer via activation of beta-catenin signaling. Breast Cancer Res. 2014;16:465.","journal-title":"Breast Cancer Res"},{"key":"1373_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/froh.2024.1363052","volume":"5","author":"WA Gonzalez-Arriagada","year":"2024","unstructured":"Gonzalez-Arriagada WA, Canedo-Marroquin G, Adorno-Farias D, Fernandez-Ramires R. New insights into the role of the oral leukoplakia microenvironment in malignant transformation. Front Oral Health. 2024;5:1363052.","journal-title":"Front Oral Health"},{"key":"1373_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/froh.2025.1605978","volume":"6","author":"S Sutera","year":"2025","unstructured":"Sutera S, Furchi OA, Pentenero M. Macrophages and the immune microenvironment in OPMDs: a systematic review of the literature. Front Oral Health. 2025;6:1605978.","journal-title":"Front Oral Health"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01373-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-026-01373-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01373-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T15:14:09Z","timestamp":1777907649000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-026-01373-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["1373"],"URL":"https:\/\/doi.org\/10.1007\/s13577-026-01373-5","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"assertion":[{"value":"21 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare they have no conflict of interest in the subject matter discussed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the institutional ethical committee: Narayana Health Medical Ethics Committee [Approval No.: NHH\/AEC-CL-2019\/379].","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent for the study was obtained from all patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"72"}}